Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology

Sarcoma

Arkansas

Little Rock : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

California

Duarte : City of Hope

A Phase I/II Study of Nelfinavir in Liposarcoma

Duarte : City of Hope

A Pivotal Trial to Determine the Efficacy and Safety of AP23573 When Administered as Maintenance Therapy to Patients with Metastatic Soft Tissue or Bone Sarcomas

Duarte : City of Hope

A Randomized, Open-Label, Multi-Center Phase III Study to Evaluate the Efficacy and Safety of Nilotinib Versus Imatinib in Adult Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)

Duarte : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Duarte : City of Hope

COG #AEWS0331: European Ewing Tumour Working Initiative of National Groups Ewing Tumor Studies 1999 (EURO-E-W.I.N.G. 99)

Duarte : City of Hope

COG#ARST0531: Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-Risk Rhabdomyosarcoma (RMS) - A Groupwide Phase III Study

Duarte : City of Hope

Phase II Study of Preoperative Intensity-Modulated Radiation Therapy for Soft-Tissue Sarcomas

Duarte : City of Hope

SARC 011, N021157: SARC Global Collaboration: Phase II Trial of R1507, A Recombinant Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas

Duarte : City of Hope

SARC-009: A Phase II Trial of Dasantinib in Advanced Sarcoma

Duarte : City of Hope

SARC011-CBP/NO21157-CBP: A Group Wide Biology and Banking Study for Phase II Studies of R1507

Los Angeles : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Santa Monica : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Stanford : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

West Hollywood : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Florida

Gainesville : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Tampa : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Georgia

Atlanta : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Savannah : Memorial Health University Medical Center

Collecting and Storing Biological Samples From Patients With Ewing Sarcoma COG AEWS07B1

Savannah : Memorial Health University Medical Center

Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

Savannah : Memorial Health University Medical Center New!

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma COG AOST0331

Idaho

Coeur D'Alene : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Maryland

Baltimore : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Bethesda : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Massachusetts

Boston : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Michigan

Ann Arbor : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Minnesota

Rochester : Research Site

120GS201 - A study of BIIB021, an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib.

Rochester : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Nebraska

Omaha : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

New Jersey

Charlotte : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

New York

Bronx : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

New York : Research Site

120GS201 - A study of BIIB021, an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib.

New York : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Oregon

Portland : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Pennsylvania

Philadelphia : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Tennessee

Nashville : Research Site

120GS201 - A study of BIIB021, an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib.

Nashville : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Texas

Houston : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Soft Tissue Sarcoma

Utah

Salt Lake City : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Washington

Seattle : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Washington, DC

Washington : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Australia

Melbourne : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Sydney : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Westmead : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Canada

Vancouver, BC : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

France

Bordeaux : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Lille : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Lille : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Lyon : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Lyon : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Marseille : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Marseille : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Nantes : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Paris : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Paris : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Toulouse : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Villejuif : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Villejuif : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Germany

Bad Saarow : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Frankfurt Am Main : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Mannheim : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Münster : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Tübingen : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Italy

Bologna : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Genova : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Milano : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Milano : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Padova : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Netherlands

Amsterdam : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Rotterdam : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Rotterdam : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Norway

Oslo : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Spain

Barcelona : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Madrid : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Palma de Mallorca : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Sweden

Lund : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Stockholm : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

United Kingdom

Birmingham : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Birmingham : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Bristol : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Glasgow : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Leeds : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

London : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

London : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Manchester : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Manchester : Research Site:

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Newcastle upon Tyne : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Surrey : Research Site:

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.